Phase 2 Adebrelimab (SHR-1316) Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Phase 2 Trial of Adjuvant Adebrelimab Combined With Capecitabine in High-Risk Resected Cholangiocarcinoma: ACHIEVE
Cholangiocarcinoma CancerAdebrelimab (SHR-1316)
The First Affiliated Hospital with Nanjing Medical University122 enrolled4 locationsNCT06607276
Recruiting
Phase 2
A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)
Adebrelimab (SHR-1316)XELOXGC/GEJC
Tianjin Medical University Cancer Institute and Hospital25 enrolled1 locationNCT06506292
Recruiting
Phase 1Phase 2
Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer
Metastatic Pancreatic CancerAdebrelimab (SHR-1316)Decitabine
Tianjin Medical University Cancer Institute and Hospital20 enrolled1 locationNCT06454448